Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4/A Aug 14, 2020 FORM 4/A
4 Aug 13, 2020 OWNERSHIP DOCUMENT
4 Aug 13, 2020 OWNERSHIP DOCUMENT
4 Aug 13, 2020 OWNERSHIP DOCUMENT
8-K Aug 11, 2020 FORM 8-K
10-Q Aug 10, 2020 FORM 10-Q
8-K Aug 10, 2020 FORM 8-K
4 Jul 8, 2020 OWNERSHIP DOCUMENT
3 Jul 8, 2020 OWNERSHIP DOCUMENT
S-8 Jun 11, 2020 FORM S-8
4 Jun 8, 2020 OWNERSHIP DOCUMENT
8-K Jun 8, 2020 FORM 8-K
10-Q/A Jun 1, 2020 FORM 10-Q/A
10-Q Jun 1, 2020 FORM 10-Q
8-K Jun 1, 2020 FORM 8-K
8-K May 28, 2020 FORM 8-K
8-K May 11, 2020 8-K
8-K May 11, 2020 FORM 8-K
EFFECT Apr 29, 2020
424B3 Apr 29, 2020 424B3
CORRESP Apr 27, 2020
UPLOAD Apr 22, 2020
S-3 Apr 17, 2020 FORM S-3
DEF 14A Apr 15, 2020 DEF 14A
4 Apr 13, 2020 OWNERSHIP DOCUMENT
← Newer Page 10 of 38 · 935 filings Older →